«Lambert-Eaton Myasthenic Syndrome

Below is an extended Lambert-Eaton Myasthenic Syndrome patents listing. Click here to return to the Lambert-Eaton Myasthenic Syndrome main in depth entry.

Patents :
US Patent No.	Title
6951924	Antibodies against secreted protein HTEBYII
7078186	Apoptosis related polynucleotides, polypeptides, and antibodies
7091315	Protein HDPBQ71
7112410	Human tumor necrosis factor TR21 and methods based thereon
7138501	Antibodies that immunospecifically bind BLyS
7141547	Albumin fusion proteins comprising GLP-1 polypeptides
7163797	50 human secreted proteins
7164004	Human tumor necrosis factor TR20 and methods based thereon
7175988	Human G-protein Chemokine Receptor (CCR5) HDGNR10
7176280	Isolated polypeptides and compositions from the venom of P. transvaalicus and methods of use
7179821	Method of treating of demyelinating diseases or conditions
7070803	Controlled release pharmaceutical composition for oral use containing midodrine and/or active metabolite, desglymidodrine
7067512	Substituted 1,4-benzodiazepines and uses thereof
6967210	Method of treating of demyelinating diseases or conditions
6979547	Methods for designing specific ion channel blockers
6979556	Separate-cistron contructs for secretion of aglycosylated antibodies from prokaryotes
6979724	Calcium channel proteins
6994857	Albumin fusion proteins
7026447	53 human secreted proteins
7026450	Ma family polypeptides and anti-Ma antibodies
7033790	Proteins and nucleic acids encoding same
7041803	Galectin 11
7063950	Nucleic acids encoding human calcium channel and methods of use thereof
7189690	Albumin fusion proteins
7189820	Antibodies against tumor necrosis factor delta (APRIL)
7196164	Secreted protein HHTLF25
7354575	Method and pharmaceutical composition for treating inflammation
7354725	Kinase peptides and antibodies
7368527	HADDE71 polypeptides
7368531	Human secreted proteins
7371388	Treatment of Sjogren's syndrome by administration of TR18 polypeptides
7381800	Antibodies to HBIMF63 polypeptide
7390637	Keratinocyte derived interferon
7393934	Human G-protein chemokine receptor (CCR5) HDGNR10
7404969	Lipid nanoparticle based compositions and methods for the delivery of biologically active molecules
7411051	Antibodies to HDPPA04 polypeptide
7282484	Anti-tumor agents
7276371	Stimulation of hematopoietic cells in vitro
7205139	Tissue plasminogen activator-like protease
7217788	Human tumor necrosis factor delta polypeptides
7220840	Antibodies that immunospecifically bind to B lymphocyte stimulator protein
7230015	Method of treating of demyelinating diseases or conditions
7232667	Keratinocyte growth factor-2 polynucleotides
7235529	Brain-associated inhibitor of tissue-type plasminogen activator
7238660	Albumin fusion proteins
7238667	Albumin fusion proteins
7241438	AK155 polypeptides
7256002	Screening for neurotoxic amino acid associated with neurological disorders
7414110	Human calcium channel compositions and methods

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.